Meta is preparing to launch two new models of Ray-Ban smart glasses designed specifically for prescription wearers, according to a Bloomberg report published Thursday. The models, codenamed Scriber and Blazer, were first seen in Federal Communications Commission filings and are expected to reach consumers next week. They do not represent a new generation of hardware. They represent something potentially more important: a distribution strategy.
Prescription glasses account for approximately 69 percent of the $223 billion global eyewear market. Meta sold more than seven million Ray-Ban and Oakley AI frames in 2025, an impressive number for a product category that barely existed three years ago, but a rounding error compared to the estimated 1.5 billion people worldwide who wear corrective lenses. The new models are Meta’s clearest attempt to move smart glasses from consumer electronics to optical retail, where customers, margins and scale are substantially larger.
What the new models are and what they are not
Scriber and Blazer are screenless AI glasses, similar in capability to the existing Ray-Ban Meta line: camera, microphone, speakers and Meta AI Integration, but without screen. Blazer will come in regular and plus sizes; Scriber appears to be a one-size-fits-all offering. Both include support for the UNII-4 Wi-Fi 6 band, an upgrade over the current models, and will ship with charging cases.
The distinction is important because Meta already sells a model equipped with a screen. The Ray-Ban Meta Display, launched at Connect 2025, includes a full-color front display, a 12-megapixel camera with 3x zoom, and is paired with a neural bracelet that reads muscle signals to navigate the interface. It costs $799. Orion, Meta’s full augmented reality prototype with holographic displays, remains a research project with no consumer release date.
Scriber and Blazer fall below both of them in the product hierarchy. Its purpose is not to showcase Meta’s most advanced technology, but to put Meta AI into frameworks that people already need to buy. The idea behind this measure is simple: if someone needs prescription glasses and is going to spend several hundred dollars at an optical store anyway, the incremental cost of making those glasses smart is significantly reduced. Mark Zuckerberg made the strategic logic explicit in a recent earnings call, noting that “Billions of people use glasses or contact lenses to correct their vision.” and suggests that it is “hard to imagine a world several years from now where the majority of glasses people use are not AI glasses.”
The EssilorLuxottica issue
The prescription twist also directly touches on the most complex relationship in Meta’s hardware business. EssilorLuxottica, the Franco-Italian conglomerate that owns Ray-Ban, Oakley, LensCrafters and Sunglass Hut, makes all of Meta’s smart glasses and controls the optical retail channel through which the new models will be sold. The partnership has yielded results, but it has also generated friction.
Bloomberg reported in February that the two companies are resolving disagreements over pricing and strategy. EssilorLuxottica’s adjusted gross margin fell 2.6 percentage points in 2025 to 60.9 percent, partly due to higher component costs required for smart glasses compared to conventional frames. Meta wanted to offer Black Friday discounts in 2023; EssilorLuxottica, which carefully guards its positioning in the luxury sector, rejected the idea. The tension is structural: Meta wants to maximize adoption and lock users into its AI ecosystem. EssilorLuxottica wants to protect the margins of a product line that is eroding them.
Prescription models could relieve that tension. Prescription lenses have higher retail prices and wider margins than non-prescription sunglasses. Lens coatings, custom polishing, and fitting appointments required for prescription orders generate additional revenue at every stage of the value chain. If smart glasses move into the prescription channel on a large scale, the economics will improve for EssilorLuxottica even when volumes increase for Meta. The companies are reportedly considering doubling their combined production target to 20 million units per year, up from an estimated capacity of 10 million by the end of 2026.
The risks in the optician’s chair
Selling smart glasses through optical retail introduces complications that consumer electronics channels do not. Opticians are trained to fit lenses, not explain AI assistants, camera privacy settings, or software updates. The customer experience at a LensCrafters is fundamentally different from the experience at a Meta Store or an Apple Store, and the staff training, product support, and return handling required for a connected device are orders of magnitude more complex than for a pair of Wayfarers.
There is also the legal exposure. Solos Technology filed a patent infringement lawsuit against Meta and EssilorLuxottica in January 2026, alleging that the Ray-Ban Meta line infringes several patents covering core smart glasses technologies and seeking “multiple billions of dollars” in damages. A second patent front, in addition to partnership tension and margin pressure, adds risk to a product line that Meta is treating as the foundation of its wearable AI strategy.
The smart glasses market itself is growing rapidly, from an estimated $2.5 billion in 2025 to a projected $14.4 billion by 2033, according to Grand View Research, but almost all of that growth is speculative and depends on whether consumers will choose connected frames when regular ones are cheaper, lighter, and glasses-free. privacy concerns. Meta’s bet is that AI functionalityspecifically the ability to ask questions, get real-time information, and interact with digital services without having to use a phone, will be compelling enough to overcome those objections.
Scriber and Blazer are not the product that will prove that bet definitively. They are the product that puts Meta’s AI into opticians’ trial trays, onto the faces of people who were going to buy new glasses anyway, and into a distribution channel that reaches billions of potential customers. Technology is incremental. Strategic ambition is not.
